Aclaris Therapeutics Inc.

NASDAQ: ACRS · Real-Time Price · USD
1.88
0.19 (11.24%)
At close: Aug 15, 2025, 3:59 PM
1.83
-2.40%
After-hours: Aug 15, 2025, 07:57 PM EDT

Aclaris Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
24.57M 39.88M 45.28M 27.35M
Short-Term Investments
89.02M 79.23M 172.29M 164.06M
Long-Term Investments
90.3M 62.77M 12.24M 34.24M
Other Long-Term Assets
3.07M 3.89M -630K 3.55M
Receivables
318K 298K 484K 623K
Inventory
n/a n/a -12.24M n/a
Other Current Assets
12.04M 9.45M 25.74M n/a
Total Current Assets
125.95M 128.86M 231.55M 205.03M
Property-Plant & Equipment
1.01M 1.62M 1.1M 1.33M
Goodwill & Intangibles
n/a 269K 6.97M 7.05M
Total Long-Term Assets
94.38M 68.55M 23.05M 46.18M
Total Assets
220.33M 197.41M 254.6M 251.21M
Account Payables
4.69M 8.88M 10.35M 9.98M
Deferred Revenue
3.89M n/a n/a 10.05M
Short-Term Debt
481K 426K 684K 693K
Other Current Liabilities
22.05M 10.37M 6.81M -4.15M
Total Current Liabilities
31.6M 30.95M 21.94M 22.93M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
11.02M 6.2M 34.67M 30.57M
Total Long-Term Liabilities
33.18M 9.27M 35.04M 30.94M
Total Liabilities
64.77M 40.23M 56.98M 53.87M
Total Debt
2.6M 3.5M 2.25M 2.89M
Common Stock
1K 1K 1K 1K
Retained Earnings
-902.86M -770.8M -682.32M -595.41M
Comprehensive Income
97K -106K -897K -224K
Shareholders Equity
155.55M 157.18M 197.62M 197.34M
Total Investments
179.33M 142M 184.54M 198.31M